Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abinopharm has commercialized several premium dietary supplement ingredients—most notably pharmaceutical-grade NMN under the AbinoNutra® brand, which has been validated in a randomized, placebo-controlled human clinical trial showing significant increases in blood NAD levels at all tested doses. The company also collaborates on other clinically validated healthy aging compounds such as L-Ergothioneine, Fisetin, Urolithin A, CaAKG, Spermidine, S-equol, and Hydroxytyrosol[1][2][7]. Their pipeline includes both marketed nutraceuticals and early-stage drug discovery programs targeting age-related diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abinopharm.